Decreased retinal vascular density associated with moderate/severe COVID-19 pneumonia
Vascular density might be a biomarker for microvascular abnormalities following COVID-19
Corneal sensitivity unaffected by COVID-19 in the acute phase
Acute infection did not impact the ability to obtain reliable test results
Study: potential biologic may treat allergic eye disease
Researchers report a recombinant biologic derived from blood-feeding ticks may be a potential treatment for allergic eye disease
UK guidelines for glaucoma treatment make significant change
The National Institute for Health and Care Excellences announced SLT as the new primary form of glaucoma intervention.
Effective treatments for presbyopia, myopia, demodex
Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly
Interventional glaucoma management: The art and science
Lee Peplinski, OD, FAAO, emphasizes the importance of interventional care in patients with glaucoma.
Focus on amblyopia, thyroid eye disease, and papilledema
Clinical pearls on amblyopia, thyroid eye disease, and papilledema treatments from SECO 2022.
Focusing on giant cell arteritis and optic neuritis
Clinical pearls on giant cell arteritis (GCA) and optic neuritis
Combatting dry eye during contact lens wear
Tools and therapies for dry eye with contact lens wear
Glaucoma: More pressures than meet the eye
Other factors, besides IOP, can contribute to glaucomatous optic nerve damage
It’s not just about the eyes but the skin too
Optometrists at the forefront of ocular basal cell and squamous cell carcinomas
COVID-19 associated with a purtscher-like retinopathy
OCT showed inner retinal hyperreflectivity, diffuse retinal thickening with intraretinal fluid, and a serous macular detachment.
Chronic bilateral dacryoadenitis related to COVID-19
SARS-CoV-2 may target lacrimal gland tissue and manifest as chronic inflammation
COVID-19 associated with maternal deaths/morbidity
Is presbyopia the newest specialty?
Latest innovations within the presbyopic landscape are proving game-changers for better patient treatment.
Complementary approach to control development of symptomatic COVID-19
New Horizons: Glaucoma challenges of vision restoration
Sustained-release injectables may be key to addressing the greatest obstacles in glaucoma.
Identifying and treating glaucoma in high myopes
Risk factors take priority
Glaucoma drugs and drug delivery: Arising from the pandemic
The future is sustained-release injectables
The glaucoma market: Rapid sustained expansion driven by novel devices, drugs
Industry keenly focused on innovations
Full vaccination status superior to no/partial vaccination status for COVID-19
Israel: 4th COVID-19 shot shows major benefits for patients over 60
Israeli researchers find a second booster shot was especially effective in individuals over 60 years of age, and “made them three times more resistant to serious illness."
COVID-19 rapid testing linked to low rate of false positive results
Canadian researchers have found that rapid antigen tests to detect the SARS-CoV-2 virus are associated with a very low rate of false positive results.
A faster path to more rapid COVID-19 diagnosis
Diagnosing COVID-19 just got faster with a test that claims to provide rapid virus detection markedly faster than reverse-transcriptase polymerase chain reaction (RT-PCR) testing.
IgG antibodies persistent in COVID-19 patients on hemodialysis
Investigators report that maintenance hemodialysis does not seem to impact the effectiveness of vaccines against the COVID-19 virus in most study patients.
COVID-19: new omicron BA.2 variant signals caution
The WHO alerted the public to a new version of Omicron, BA. 2, following its predecessor, Omicron BA.1.
Pupillary size variations in cases of active and resolved COVID-19
Significant differences were found in the pupillary diameters between when the virus was active and 3 months later, Turkish investigators report.
Pfizer and BioNTech launch omicron-specific COVID-19 vaccine trial
Manufacturing of the omicron-specific vaccine has already begun.
Conflicting evidence on Vitamin D efficacy in COVID-19 cases
Saudi Arabian investigators have determined that Vitamin D levels are not protective against the severity or the outcomes of COVID-19 infections.
Genetics linked to COVID-19-related loss of smell, taste
Genetics researchers reported identifying a genetic link to the biologic mechanisms responsible for COVID-19-related loss of smell or taste.
2 Clarke Drive Cranbury, NJ 08512